| Literature DB >> 27016543 |
Jorge I Ugaz1, Minki Chatterji1, James N Gribble2, Kathryn Banke2.
Abstract
As programs continue to expand access to family planning information, services, and products, it is critical that these efforts be undertaken with an equity lens, ensuring that regardless of socioeconomic status, all women and couples can use the method that meets their needs. This study explores the relationship between household wealth and the use of long-acting and permanent methods (LAPMs) versus short-acting methods of contraception among modern method users, using multivariate analyses based on Demographic Health Survey data from 30 developing countries conducted between 2006 and 2013. Overall, and controlling for relevant individual and household characteristics including age, number of living children, education, and urban/rural residence, we found that wealthier women were more likely than poorer women to use LAPMs instead of short-acting methods: 20 of the 30 countries showed a positive and statistically significant association between wealth and LAPM use. For 10 of those countries, however, LAPM use was significantly higher only for the top (1 or 2) wealthiest quintiles. Eight countries showed no broad pattern of association, while in 2 countries-Bangladesh and India-poorer women were more likely to use LAPMs than wealthier women. The positive association between wealth and LAPM use was found most consistently in the Latin American and the Caribbean countries in our sample. These findings can help program implementers respond better to women's needs for modern contraception, especially in reaching women from lower- and middle-income households. © Ugaz et al.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27016543 PMCID: PMC4807748 DOI: 10.9745/GHSP-D-15-00234
Source DB: PubMed Journal: Glob Health Sci Pract ISSN: 2169-575X
Countries and Survey Years Included in the Analysis
| Region/Country | Survey Year |
|---|---|
| Burundi | 2010 |
| Cameroon | 2011 |
| Ethiopia | 2011 |
| Kenya | 2009 |
| Lesotho | 2009 |
| Madagascar | 2008 |
| Malawi | 2010 |
| Namibia | 2006 |
| Nigeria | 2013 |
| Rwanda | 2010 |
| Senegal | 2012 |
| Swaziland | 2006 |
| Tanzania | 2010 |
| Zambia | 2007 |
| Zimbabwe | 2010 |
| Bangladesh | 2011 |
| Cambodia | 2010 |
| Egypt | 2008 |
| India | 2006 |
| Indonesia | 2007 |
| Jordan | 2009 |
| Nepal | 2011 |
| Pakistan | 2007 |
| Philippines | 2008 |
| Bolivia | 2008 |
| Colombia | 2010 |
| Dominican Republic | 2013 |
| Guyana | 2009 |
| Haiti | 2012 |
| Peru | 2008 |
Source: Demographic and Health Surveys.
Use of Contraception Among Women of Reproductive Age,a by Type of Method
| Country | None | Traditional | Short-acting | LAPMs | N |
|---|---|---|---|---|---|
| Burundi | 78% | 4% | 14% | 4% | 5,660 |
| Cameroon | 69% | 10% | 20% | 1% | 11,940 |
| Ethiopia | 71% | 1% | 23% | 4% | 11,280 |
| Kenya | 58% | 5% | 29% | 7% | 6,414 |
| Lesotho | 56% | 1% | 39% | 4% | 6,156 |
| Madagascar | 60% | 11% | 26% | 3% | 13,872 |
| Malawi | 54% | 4% | 31% | 11% | 17,701 |
| Namibia | 41% | 1% | 50% | 7% | 7,679 |
| Nigeria | 80% | 7% | 12% | 1% | 25,244 |
| Rwanda | 55% | 6% | 33% | 7% | 8,591 |
| Senegal | 86% | 1% | 11% | 2% | 10,761 |
| Swaziland | 51% | 2% | 42% | 5% | 3,837 |
| Tanzania | 62% | 7% | 25% | 6% | 7,403 |
| Zambia | 61% | 7% | 30% | 2% | 5,440 |
| Zimbabwe | 44% | 1% | 50% | 4% | 6,765 |
| Bangladesh | 39% | 9% | 44% | 8% | 16,654 |
| Cambodia | 51% | 15% | 28% | 6% | 11,912 |
| Egypt | 38% | 3% | 21% | 39% | 14,950 |
| India | 41% | 8% | 9% | 43% | 88,075 |
| Indonesia | 39% | 4% | 46% | 11% | 30,910 |
| Jordan | 36% | 19% | 18% | 27% | 8,851 |
| Nepal | 48% | 7% | 18% | 27% | 9,228 |
| Pakistan | 62% | 10% | 16% | 12% | 12,063 |
| Philippines | 50% | 17% | 21% | 13% | 8,889 |
| Bolivia | 44% | 23% | 19% | 13% | 12,697 |
| Colombia | 28% | 5% | 26% | 41% | 42,242 |
| Dominican Republic | 31% | 3% | 26% | 39% | 7,524 |
| Guyana | 57% | 3% | 30% | 11% | 4,008 |
| Haiti | 69% | 7% | 21% | 3% | 7,861 |
| Peru | 36% | 20% | 30% | 13% | 31,261 |
Abbreviation: LAPMs, long-acting and permanent methods.
Unit of analysis is women of reproductive (15–49 years old) who have ever been sexually active and who were not currently pregnant.
Source: Demographic and Health Surveys (various years).
Descriptive Statistics of Study Sample of Modern Contraceptive Usersa
| Country | Average Age | Average No. of Children | Education | Living in Urban Areas | Type of Modern Method Used | N | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| None | Primary | High School | College or Higher | Short-Acting Methods | LAPMs | ||||||
| Burundi | 30.4 | 3.5 | 43% | 44% | 11% | 2% | 16% | 78% | 22% | 1,075 | |
| Cameroon | 27.3 | 2.0 | 4% | 26% | 58% | 12% | 73% | 94% | 6% | 2,454 | |
| Ethiopia | 29.5 | 3.1 | 51% | 35% | 7% | 7% | 33% | 85% | 15% | 2,793 | |
| Kenya | 31.7 | 3.1 | 3% | 56% | 30% | 10% | 30% | 80% | 20% | 2,225 | |
| Lesotho | 30.2 | 2.0 | 1% | 43% | 47% | 9% | 40% | 91% | 9% | 2,489 | |
| Madagascar | 30.7 | 3.2 | 12% | 54% | 32% | 2% | 19% | 90% | 10% | 3,889 | |
| Malawi | 30.5 | 3.5 | 15% | 65% | 18% | 2% | 21% | 73% | 27% | 7,449 | |
| Namibia | 29.7 | 2.0 | 4% | 21% | 66% | 9% | 59% | 87% | 13% | 4,321 | |
| Nigeria | 29.8 | 2.5 | 9% | 20% | 50% | 22% | 55% | 90% | 10% | 3,117 | |
| Rwanda | 31.5 | 3.3 | 16% | 72% | 10% | 2% | 14% | 83% | 17% | 3,410 | |
| Senegal | 31.9 | 3.5 | 45% | 34% | 18% | 4% | 69% | 83% | 17% | 1,250 | |
| Swaziland | 29.2 | 2.5 | 6% | 28% | 55% | 12% | 32% | 89% | 11% | 1,837 | |
| Tanzania | 30.5 | 3.1 | 14% | 72% | 14% | 1% | 33% | 80% | 20% | 2,091 | |
| Zambia | 29.5 | 3.3 | 10% | 53% | 30% | 7% | 46% | 93% | 7% | 1,790 | |
| Zimbabwe | 30.2 | 2.6 | 2% | 30% | 64% | 5% | 37% | 92% | 8% | 3,690 | |
| Bangladesh | 29.8 | 2.4 | 25% | 30% | 36% | 8% | 27% | 84% | 16% | 8,716 | |
| Cambodia | 32.6 | 2.8 | 19% | 57% | 23% | 1% | 16% | 83% | 17% | 3,993 | |
| Egypt | 33.9 | 3.1 | 30% | 12% | 46% | 12% | 44% | 35% | 65% | 8,524 | |
| India | 34.2 | 2.9 | 45% | 17% | 32% | 6% | 35% | 17% | 83% | 45,224 | |
| Indonesia | 33.3 | 2.3 | 5% | 48% | 41% | 7% | 41% | 81% | 19% | 16,963 | |
| Jordan | 34.8 | 4.3 | 2% | 5% | 61% | 32% | 87% | 40% | 60% | 3,831 | |
| Nepal | 34.0 | 2.9 | 54% | 18% | 23% | 5% | 15% | 40% | 60% | 4,194 | |
| Pakistan | 34.4 | 4.2 | 51% | 18% | 21% | 11% | 41% | 57% | 43% | 3,532 | |
| Philippines | 33.7 | 3.1 | 0% | 21% | 46% | 32% | 53% | 62% | 38% | 3,024 | |
| Bolivia | 32.0 | 2.8 | 4% | 41% | 34% | 21% | 73% | 59% | 41% | 4,375 | |
| Colombia | 32.7 | 2.1 | 2% | 26% | 49% | 24% | 79% | 39% | 61% | 27,532 | |
| Dominican Rep. | 33.1 | 2.5 | 2% | 36% | 36% | 26% | 75% | 40% | 60% | 5,026 | |
| Guyana | 32.1 | 2.5 | 1% | 20% | 70% | 9% | 32% | 73% | 27% | 1,541 | |
| Haiti | 29.7 | 2.5 | 21% | 35% | 38% | 5% | 50% | 86% | 14% | 1,874 | |
| Peru | 33.1 | 2.5 | 3% | 26% | 41% | 30% | 75% | 70% | 30% | 13,770 | |
Abbreviation: LAPMs, long-acting and permanent methods.
Study sample is limited to women of reproductive age who have ever been sexually active, who were not pregnant at the time of the survey, and who reported current use of a modern contraceptive method.
Source: Demographic and Health Surveys (various years).
Proportion of Modern Method Usersa Using LAPMs, by Wealth Quintile
| Country | Wealth Quintile | |||||
|---|---|---|---|---|---|---|
| Q1 (Poorest) | Q2 | Q3 | Q4 | Q5 (Wealthiest) | ||
| Burundi | 22% | 15% | 20% | 23% | 26% | |
| Cameroon | 7% | 8% | 8% | 7% | 5% | |
| Ethiopia | 16% | 21% | 16% | 16% | 12% | |
| Kenya | 14% | 16% | 21% | 21% | 21% | |
| Lesotho | 3% | 6% | 7% | 10% | 11% | |
| Madagascar | 8% | 7% | 7% | 12% | 13% | |
| Malawi | 24% | 23% | 26% | 28% | 32% | |
| Namibia | 5% | 6% | 8% | 13% | 22% | |
| Nigeria | 6% | 8% | 10% | 9% | 12% | |
| Rwanda | 12% | 15% | 15% | 18% | 25% | |
| Senegal | 21% | 17% | 14% | 15% | 19% | |
| Swaziland | 6% | 9% | 10% | 9% | 16% | |
| Tanzania | 17% | 24% | 20% | 22% | 18% | |
| Zambia | 2% | 5% | 6% | 5% | 13% | |
| Zimbabwe | 6% | 6% | 5% | 7% | 14% | |
| Bangladesh | 21% | 18% | 16% | 13% | 10% | |
| Cambodia | 14% | 14% | 12% | 17% | 31% | |
| Egypt | 53% | 61% | 64% | 72% | 73% | |
| India | 90% | 89% | 88% | 83% | 71% | |
| Indonesia | 14% | 17% | 17% | 19% | 29% | |
| Jordan | 56% | 59% | 57% | 60% | 69% | |
| Nepal | 54% | 64% | 66% | 64% | 50% | |
| Pakistan | 50% | 45% | 47% | 39% | 40% | |
| Philippines | 33% | 38% | 39% | 40% | 41% | |
| Bolivia | 25% | 33% | 39% | 44% | 51% | |
| Colombia | 61% | 62% | 61% | 62% | 59% | |
| Dominican Republic | 52% | 58% | 65% | 62% | 62% | |
| Guyana | 24% | 27% | 29% | 27% | 26% | |
| Haiti | 25% | 18% | 19% | 11% | 10% | |
| Peru | 18% | 26% | 27% | 34% | 34% | |
Abbreviations: LAPMs, long-acting and permanent methods; Q, quintile.
Study sample is limited to women of reproductive age who have ever been sexually active, who were not pregnant at the time of the survey, and who reported current use of a modern contraceptive method.
Source: Demographic and Health Surveys (various years).
Adjusted Odds Ratios for Relationship Between Wealth Quintile and Use of LAPMs vs. Short-Acting Methods Among Study Sample of Modern Method Usersa
| Country | Q1 (Poorest) | Q2 | Q3 | Q4 | Q5 (Wealthiest) | N |
|---|---|---|---|---|---|---|
| Burundi | 1.00 | 0.59 | 0.81 | 0.98 | 0.99 | 1,075 |
| Cameroon | 1.00 | 2.04 | 2.13 | 2.69 | 2.70 | 2,454 |
| Ethiopia | 1.00 | 1.47 | 1.07 | 1.04 | 0.81 | 2,793 |
| Kenya | 1.00 | 0.96 | 1.21 | 1.35 | 2.61** | 2,225 |
| Lesotho | 1.00 | 2.53 | 2.46 | 5.24 | 6.59 | 2,489 |
| Madagascar | 1.00 | 0.79 | 0.70 | 1.31 | 1.21 | 3,889 |
| Malawi | 1.00 | 0.99 | 1.21 | 1.30 | 1.74 | 7,449 |
| Namibia | 1.00 | 1.02 | 1.25 | 2.37 | 5.08 | 4,318 |
| Nigeria | 1.00 | 1.65 | 2.17 | 2.27 | 2.28 | 3,117 |
| Rwanda | 1.00 | 1.22 | 1.38 | 1.57 | 2.02 | 3,410 |
| Senegal | 1.00 | 0.74 | 0.48 | 0.56 | 0.83 | 1,250 |
| Swaziland | 1.00 | 1.55 | 1.63 | 1.34 | 1.86 | 1,837 |
| Tanzania | 1.00 | 1.62 | 1.37 | 1.94 | 1.48 | 2,091 |
| Zambia | 1.00 | 3.31 | 4.51 | 4.71 | 11.34 | 1,790 |
| Zimbabwe | 1.00 | 1.04 | 0.72 | 1.05 | 1.80 | 3,690 |
| Bangladesh | 1.00 | 0.80 | 0.69 | 0.59 | 0.54 | 8,755 |
| Cambodia | 1.00 | 0.96 | 0.78 | 0.99 | 1.76 | 3,993 |
| Egypt | 1.00 | 1.29 | 1.42 | 1.97 | 1.94 | 8,524 |
| India | 1.00 | 0.87 | 0.83 | 0.77 | 0.53 | 45,224 |
| Indonesia | 1.00 | 1.15 | 1.05 | 1.04 | 1.41 | 16,963 |
| Jordan | 1.00 | 1.09 | 1.04 | 1.12 | 1.58 | 3,831 |
| Nepal | 1.00 | 1.74 | 1.97 | 2.33 | 1.84 | 4,194 |
| Pakistan | 1.00 | 0.85 | 1.05 | 0.88 | 1.06 | 3,532 |
| Philippines | 1.00 | 1.18 | 1.05 | 1.08 | 1.20 | 3,024 |
| Bolivia | 1.00 | 1.80 | 2.23 | 2.72 | 3.19 | 4,375 |
| Colombia | 1.00 | 1.34 | 1.45 | 1.70 | 1.68 | 27,532 |
| Dominican Republic | 1.00 | 1.52 | 1.74 | 1.40 | 1.84 | 5,026 |
| Guyana | 1.00 | 1.27 | 1.50 | 1.50 | 1.53 | 1,541 |
| Haiti | 1.00 | 0.55 | 0.58 | 0.52 | 0.54 | 1,874 |
| Peru | 1.00 | 1.42 | 1.72 | 2.65 | 2.23 | 13,770 |
Abbreviations: LAPMs, long-acting and permanent methods; Q, quintile.
Study sample is limited to women of reproductive age who have ever been sexually active, who were not pregnant at the time of the survey, and who reported current use of a modern contraceptive method.
P < .10,
P < .05,
P < .01
Source: Demographic and Health Surveys (various years).